Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 07 2025
0mins
Source: Globenewswire
Ceribell's Legal Action: Ceribell, Inc. has filed complaints against Natus Medical for patent infringement and unfair competition, seeking an investigation by the U.S. International Trade Commission and a court ruling in Delaware to protect its EEG technology patents.
Company Overview: Ceribell is a medical technology company specializing in point-of-care EEG systems designed for acute care settings, utilizing advanced AI algorithms for rapid diagnosis and monitoring of neurological conditions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
